Erasca, Inc. - Common Stock (ERAS)

Historical Holders from Q3 2021 to Q2 2025

Symbol
ERAS on Nasdaq
CUSIP
29479A108
Type / Class
Equity / Common Stock
Shares outstanding
285M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
218M
Holdings value
$277M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
141
Number of buys
83
Number of sells
-71
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Erasca, Inc. - Common Stock (ERAS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 7.2% $32.1M 20.3M T. Rowe Price Investment Management, Inc. Jun 30, 2025
Logos Global Management LP 5.3% $23.9M 15.1M Logos Global Management LP Jun 30, 2025
Frazier Life Sciences Public Fund, L.P. 5.3% -33.8% $23.8M -$11.9M 15M -33.4% Frazier Life Sciences Public Fund, L.P. Jun 30, 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 5.1% +17.5% $22.9M $3.46M 14.5M +17.8% Suvretta Capital Management, LLC Jun 30, 2025
NOVARTIS PHARMA AG 4.4% $14.9M 12.3M Novartis Pharma AG Dec 31, 2024

Institutional Holders of Erasca, Inc. - Common Stock (ERAS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 218M $277M -$8.2M $1.27 141
2025 Q1 224M $307M -$9.73M $1.37 151
2024 Q4 231M $579M -$3.89M $2.51 144
2024 Q3 232M $633M +$46.9M $2.73 130
2024 Q2 204M $480M +$260M $2.36 124
2024 Q1 2.53M $5.22M -$8.48M $2.06 11
2023 Q4 34.3K $73.1K +$3.29K $2.13 1
2023 Q3 71.3M $140M -$6.33M $1.97 106
2023 Q2 74.3M $205M -$10.9M $2.76 109
2023 Q1 78M $235M -$11.5M $3.01 114
2022 Q4 79.6M $343M +$2.38M $4.31 103
2022 Q3 80.2M $626M +$33.5M $7.80 80
2022 Q2 76.6M $427M +$21.1M $5.57 81
2022 Q1 72.8M $626M +$45.2M $8.60 77
2021 Q4 63.6M $987M +$63.6M $15.58 58
2021 Q3 44.1M $919M +$919M $21.22 53